About
Ipremom is a Spanish startup focused on maternal-fetal health, developing innovative diagnostic solutions. Their primary product, the MaiRa Preeclampsia Test, utilizes a 36-gene cell-free RNA signature and an AI-driven software platform to predict the risk of early-onset preeclampsia in pregnant women during their first trimester. This early detection aims to enable timely interventions and improve outcomes for both mothers and babies.
Key facts
At-a-glance profile data
- Website
- ipremom.com
- Headquarters
- Paterna, Spain
- Founded
- 2019
- Employees
- 20
- Total funding
- $16M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 2 Sept 2026 | Seed | $16M | - |
Tech stack
Detected on ipremom.com, last scanned 17 Sept 2026. Run your own scan
- Compliance
- GDPR, CCPA
- Frontend
- jQuery
- Analytics
- Matomo
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
Frequently asked
Is iPremom Pregnancy Healthcare Diagnostics S.L. trustworthy and reputable?
StartupHub's Data Trust & Reputation score for iPremom Pregnancy Healthcare Diagnostics S.L. is 68 out of 100, based on site security posture and privacy practices.
How much funding has iPremom Pregnancy Healthcare Diagnostics S.L. raised?
iPremom Pregnancy Healthcare Diagnostics S.L. has raised a total of $16M in funding. The most recent round on record is Seed.
How many employees does iPremom Pregnancy Healthcare Diagnostics S.L. have?
iPremom Pregnancy Healthcare Diagnostics S.L. has approximately 20 people on record.